SCHEMBL22011357

SCHEMBL22011357

CCCNc1ccc(F)c(F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.46
RECQL P46063 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MAPT P10636 4/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
PABPC1 P11940 1/20 0.45
HPGD P15428 1/20 0.45
TSHR P16473 1/20 0.45
RAPGEF4 Q8WZA2 1/20 0.44
ALDH3A1 P30838 1/20 0.41
AR P10275 2/20 0.40
ALDH1A1 P00352 1/20 0.40
POLB P06746 1/20 0.40
ABL1 P00519 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SOS1 Q07889 1/20 0.38
TNIK Q9UKE5 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29659123 0.84 MAPT (0.46) RECQLSMN1; SMN2MAPTMEN1KMT2A
SCHEMBL631579 0.84 MAPT (0.46) RECQLSMN1; SMN2MAPTMEN1KMT2A
SCHEMBL17350927 0.84 ABL1 (0.57) RECQLSMN1; SMN2MAPTMEN1KMT2A
SCHEMBL18893492 0.83 HTT (0.44) TRPA1MAPTMEN1KMT2ARAPGEF4
SCHEMBL25121907 0.82 ALDH1A1 (0.43) TRPA1MAPTMEN1KMT2AAR
SCHEMBL22375325 0.82 TRPA1 (0.40) TRPA1RECQLSMN1; SMN2MAPTMEN1
SCHEMBL28134076 0.80 MAPT (0.46) RECQLSMN1; SMN2MAPTMEN1KMT2A
SCHEMBL12963475 0.79 SLC6A4 (0.36) TRPA1RECQLSMN1; SMN2MAPTMEN1
SCHEMBL13159605 0.79 TRPA1 (0.35) TRPA1RECQLSMN1; SMN2MAPTMEN1
SCHEMBL6066284 0.79 AR (0.51) TRPA1ARCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662193-B2 Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyloid-like proteins AC IMMUNE SA (CH) 2020-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662193-B2 Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyloid-like proteins APP, BACE1, PSEN1 TRPA1 4118/4885RECQL 774/4885SMN1; SMN2 1891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.